AKT regulates androgen receptor-dependent growth and psa expression in prostate cancer

Advances in Experimental Medicine and Biology

Volumn 617, Issue , 2008, Pages 397-405

  Mikhailova, Margarita ^a   Wang, Yu ^a   Bedolla, Roble ^a   Lu, Xiao Hua ^a   Kreisberg, Jeffrey I ^a   Ghosh, Paramita M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN; PROTEIN KINASE B; ANILIDE; ANTIANDROGEN; AR PROTEIN, HUMAN; BICALUTAMIDE; NITRILE; TOLUENESULFONIC ACID DERIVATIVE;

CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ARTICLE; CELL CULTURE; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; MALE; METABOLISM; NEOPLASM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROSTATE TUMOR; SIGNAL TRANSDUCTION;

ANDROGEN ANTAGONISTS; ANDROGENS; ANILIDES; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; NITRILES; PHOSPHORYLATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TOSYL COMPOUNDS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 46749104770     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-69080-3_38     Document Type: Conference Paper

References (15)

1. Edwards J, Bartlett JM (2005) The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor. BJU Int 95, 1320-1326.
2. Petrylak D (2005) Therapeutic options in androgen-independent prostate cancer: building on docetaxel. BJU Int 96 (Suppl 2), 41-46.
3. Murillo H, Huang H, Schmidt LJ, et al. (2001) Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. Endocrinology 142, 4795-4805.
4. Ghosh PM, Malik SN, Bedolla RG, et al. (2005) Signal transduction pathways in androgendependent and -independent prostate cancer cell proliferation. Endocr Relat Cancer 12, 119-134.
5. Majumder PK, Sellers WR (2005) Akt-regulated pathways in prostate cancer. Oncogene 24, 7465-7474.
6. Graff JR, Konicek BW, McNulty AM, et al. (2000) Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression. J Biol Chem 275, 24500-24505.
7. Culig Z, Hobisch A, Bartsch G, et al. (2000) Androgen receptor - an update of mechanisms of action in prostate cancer. Urol Res 28, 211-219.
8. Lin HK, Yeh S, Kang HY, et al. (2001) Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc Natl Acad Sci USA 98, 7200-7205.
9. Wen Y, Hu MC, Makino K, et al. (2000) HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res 60, 6841-6845.
10. Xin L, Teitell MA, Lawson DA, et al. (2006) Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor. Proc Natl Acad Sci USA 103, 7789-7794.
11. Feldman BJ, Feldman D (2001) The development of androgen-independent prostate cancer. Nat Rev Cancer 1, 34-45.
12. Wu X, Senechal K, Neshat MS, et al. (1998) The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA 95, 15587-15591.
13. Thalmann GN, Anezinis PE, Chang SM, et al. (1994) Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54, 2577-2581.
14. Haag P, Bektic J, Bartsch, et al. (2005) Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. J Steroid Biochem Mol Biol 96, 251-258.
15. Czauderna F, Fechtner M, Aygun H, et al. (2003) Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA. Nucleic Acids Res 31, 670-682.